Preclinical Development of Mahanine-Enriched Fraction from Indian Spice <i>Murraya koenigii</i> for the Management of Cancer: Efficacy, Temperature/pH stability, Pharmacokinetics, Acute and Chronic Toxicity (14-180 Days) Studies

<div>MEF<sub>M2</sub> is stable at a wide range of pH. (a) Schematic image showing the steps involved in MEF<sub>M2</sub> pH stability for 2-3 h analysis. (b) A representative HPLC profile of freshly prepared MEF<sub>M2</sub> and the same exposure to different pH conditions for 2 h. The mahanine peak is indicated with an arrow.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Preclinical Development of Mahanine-Enriched Fraction from Indian Spice <i>Murraya koenigii</i> for the Management of Cancer: Efficacy, Temperature/pH stability, Pharmacokinetics, Acute and Chronic Toxicity (14-180 Days) Studies 

Figure 3 | Preclinical Development of Mahanine-Enriched Fraction from Indian Spice Murraya koenigii for the Management of Cancer: Efficacy, Temperature/pH stability, Pharmacokinetics, Acute and Chronic Toxicity (14-180 Days) Studies 